Collaborators:

Amrutkar M, Guttorm SJT, Finstadsveen AV, Labori KJ, Eide L, Rootwelt H, Elgstøen KBP, Gladhaug IP, Verbeke CS (2024)
Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer
Mol Oncol (in press)
DOI 10.1002/1878-0261.13759, PubMed 39545923

Janssen BV, Oteman B, Ali M, Valkema PA, Adsay V, Basturk O, Chatterjee D, Chou A, Crobach S, Doukas M, Drillenburg P, Esposito I, Gill AJ, Hong SM, Jansen C, Kliffen M, Mittal A, Samra J, van Velthuysen MF, Yavas A, Kazemier G, Verheij J, Steyerberg E, Besselink MG, Wang H et al. (2024)
Artificial Intelligence-based Segmentation of Residual Pancreatic Cancer in Resection Specimens Following Neoadjuvant Treatment (ISGPP-2): International Improvement and Validation Study
Am J Surg Pathol, 48 (9), 1108-1116
DOI 10.1097/PAS.0000000000002270, PubMed 38985503

Farnes I, Lund-Iversen M, Aabakken L, Verbeke C, Labori KJ (2024)
Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer - real world data from the NORPACT-2 study
Scand J Gastroenterol, 59 (9), 1093-1096
DOI 10.1080/00365521.2024.2373115, PubMed 38957079